Zobrazeno 1 - 10
of 26
pro vyhledávání: '"William H, Cooner"'
Autor:
Mark S. Austenfeld, Joseph E. Oesterling, Harry C. Miller, John H. Wasson, William H. Cooner, Stephen R. Smalley, Claus G. Roehrborn, Ian M. Thompson, Martin I. Resnick, Richard G. Middleton, Roy J. Correa, Scott A. Optenberg
Publikováno v:
Journal of Urology. 162:107-112
The American Urological Association Prostate Cancer Clinical Guidelines Panel reviewed 12,501 publications on prostate cancer from 1955 to 1992 to determine whether the complication rates of external beam radiation therapy, interstitial radiotherapy
Autor:
Rizk El-Galley, Niall T.M. Galloway, Sam D. Graham, William H. Cooner, Thomas E. Keane, W.H. Sanders, John A. Petros
Publikováno v:
Urology. 46:200-204
Objectives Prostate-specific antigen (PSA) has become the most useful serum tumor marker in the diagnosis and screening of prostate adenocarcinoma. The currently cited reference range of normal (0 to 4.0 ng/mL monoclonal) lacks both the sensitivity a
Publikováno v:
Journal of Urology. 153:1160-1163
Several investigations have determined that the serum prostate specific antigen (PSA) concentration is dependent upon patient age and, as a result, reference ranges wider than 0.0 to 4.0 ng./ml. have been suggested for men 60 years old or older. To d
Autor:
William H. Cooner
Publikováno v:
Urologic Clinics of North America. 20:575-579
SUMMARY It is evident that the ideal tumor marker is not, nor should it be, a perfect tumor marker given the present level of our knowledge about prostate cancer. Further refinement of our information about prognosis and optimal treatment of this dis
Autor:
Aaron E. Katz, Matthew Whang, Carl A. Olsson, Eric Seaman, Mitchell C. Benson, William H. Cooner
Publikováno v:
Urologic Clinics of North America. 20:653-663
Prostate Specific Antigen (PSA) is the most accurate serum marker for cancer of the prostate. However, sensitivity and specificity are suboptimal, especially at the intermediate levels between 4.1 and 10.0 ng/ml (monoclonal). For intermediate PSA lev
Autor:
George W. Jones, Peter T. Scardino, Louis Denis, William H. Cooner, David G. Bostwick, Gerald P. Murphy
Publikováno v:
Cancer. 70:291-301
There are a number of similarities between benign prostatic hyperplasia (BPH) and cancer. Both display a parallel increase in prevalence with patient age according to autopsy studies (86.2% and 43.6%, respectively, by the ninth decade), although canc
Autor:
William H. Cooner
Publikováno v:
Journal of Endourology. 6:265-268
Prostate cancer may be suspected by digital rectal examination (DRE), serum marker abnormality, or transrectal ultrasound of the prostate (TRUS), but its presence must be confirmed by biopsy. A TRU...
Autor:
William H. Cooner
Publikováno v:
The Prostate. 21:3-10
Most patients with prostate cancer have disease that has extended beyond the confines of the gland at the time of diagnosis. The effect of earlier detection on morbidity and death requires further study, as does assessment of prognostic factors and o
Autor:
William H, Cooner, B R, Mosley, Charles L, Rutherford, Jeff H, Beard, Harry S, Pond, William J, Terry, Todd C, Igel, Donald D, Kidd
Publikováno v:
The Journal of urology. 167(2 Pt 2)
Publikováno v:
Urology. 43(5)
Objective. This study evaluates the accuracy of comparing serum prostate-specific antigen (PSA) levels in the range between 4.1 ng/mL and 10.0 ng/mL (monoclonal) to the volume of the transition zone (TZ) of the prostate and total gland volume as a pr